Lactobacillus salivarius UCC118 and Reduced Risk of Colorectal Cancer

• Engineered Probiotic-Based Biomaterials for Inflammatory Bowel Disease Treatment.

  • 2025-02-18
  • Review
  • Theranostics 15(8)
  • • Guangze Sang
    • Bingkai Wang
    • Yujie Xie
    • Yu Chen
    • Feng Yang

  • PubMed: 40093907
  • DOI: 10.7150/thno.103983

  5 Insights on

  • Reduced Risk of Colorectal Cancer

  • Low evidence

  Lactobacillus salivarius UCC118 showed a statistically significant reduction in colorectal cancer in a mouse model

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes